134 related articles for article (PubMed ID: 36695080)
21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
22. ICON 2019-International Scientific Tendinopathy Symposium Consensus: There are nine core health-related domains for tendinopathy (CORE DOMAINS): Delphi study of healthcare professionals and patients.
Vicenzino B; de Vos RJ; Alfredson H; Bahr R; Cook JL; Coombes BK; Fu SN; Gravare Silbernagel K; Grimaldi A; Lewis JS; Maffulli N; Magnusson SP; Malliaras P; Mc Auliffe S; Oei EHG; Purdam C; Rees JD; Rio EK; Scott A; Speed C; Akker-Scheek IVD; Weir A; Wolf JM; Zwerver J
Br J Sports Med; 2020 Apr; 54(8):444-451. PubMed ID: 31685525
[TBL] [Abstract][Full Text] [Related]
23. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.
Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT;
Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299
[TBL] [Abstract][Full Text] [Related]
24. Which outcomes have been measured in hand eczema trials? A systematic review.
Rönsch H; Apfelbacher C; Brans R; Matterne U; Molin S; Ofenloch R; Oosterhaven JAF; Schuttelaar MLA; Weisshaar E; Yew YW; Bauer A
Contact Dermatitis; 2019 Apr; 80(4):201-207. PubMed ID: 30632613
[TBL] [Abstract][Full Text] [Related]
25. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
Spuls PI; Gerbens LAA; Simpson E; Apfelbacher CJ; Chalmers JR; Thomas KS; Prinsen CAC; von Kobyletzki LB; Singh JA; Williams HC; Schmitt J;
Br J Dermatol; 2017 Apr; 176(4):979-984. PubMed ID: 27858989
[TBL] [Abstract][Full Text] [Related]
26. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
[TBL] [Abstract][Full Text] [Related]
27. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
[TBL] [Abstract][Full Text] [Related]
28. Measuring atopic eczema symptoms in clinical practice: The first consensus statement from the Harmonising Outcome Measures for Eczema in clinical practice initiative.
Leshem YA; Chalmers JR; Apfelbacher C; Furue M; Gerbens LAA; Prinsen CAC; Schmitt J; Spuls PI; Thomas KS; Williams HC; Simpson EL;
J Am Acad Dermatol; 2020 May; 82(5):1181-1186. PubMed ID: 31926221
[TBL] [Abstract][Full Text] [Related]
29. Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.
Rönsch H; Schiffers F; Ofenloch R; Weisshaar E; Buse AS; Hansen A; John SM; Giménez Arnau AM; Pesqué D; Agner T; Nørreslet LB; Loman L; Romeijn GLE; Schuttellaar MLA; Košćec Bjelajac A; Macan J; Apfelbacher C; Bauer A
J Eur Acad Dermatol Venereol; 2023 Jul; 37(7):1396-1405. PubMed ID: 36950901
[TBL] [Abstract][Full Text] [Related]
30. Core outcomes for pressure ulcer prevention trials: results of an international consensus study: Classification: Outcomes and qualitative research.
Lechner A; Coleman S; Balzer K; Kirkham JJ; Muir D; Nixon J; Kottner J
Br J Dermatol; 2022 Nov; 187(5):743-752. PubMed ID: 35789479
[TBL] [Abstract][Full Text] [Related]
31. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
Trials; 2014 Dec; 15():511. PubMed ID: 25540987
[TBL] [Abstract][Full Text] [Related]
32. Novel mixed-method, inclusive protocol involving global key stakeholders, including carers as experts, to co-develop relevant Caregiver-Reported Outcome Domains (CRODs) in skin disease.
Walsh C; Leavey G; Mc Laughlin M; Paller AS; Irvine AD; Browne F; Mellerio JE; Bewley A
BMJ Open; 2023 Jan; 13(1):e068893. PubMed ID: 36657764
[TBL] [Abstract][Full Text] [Related]
33. Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.
Reynolds KA; Schlessinger DI; Yanes AF; Godinez-Puig V; Chen BR; Kurta AO; Cotseones JK; Chiren SG; Iyengar S; Ibrahim SA; Kang BY; Worley B; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood CA; Kim JYS; Lawrence N; Lee EH; Lissner GS; Marghoob AA; Guminiski A; Matin RN; Mattox AR; Mittal BB; Thomas JR; Zhou XA; Zloty D; Hughes BGM; Nottage MK; Green AC; Testori AAE; Argenziano G; Longo C; Zalaudek I; Lebbe C; Malvehy J; Saiag P; Cernea SS; Schmitt J; Kirkham JJ; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
Br J Dermatol; 2021 Jun; 184(6):1113-1122. PubMed ID: 33236347
[TBL] [Abstract][Full Text] [Related]
34. A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.
Langbroek GB; Wolkerstorfer A; Horbach SER; Spuls PI; Kelly KM; Robertson SJ; van Raath MI; Al-Niaimi F; Kono T; Boixeda P; Laubach HJ; Badawi AM; Rubin AT; Haedersdal M; Manuskiatti W; van der Horst CMAM; Ubbink DT;
Br J Dermatol; 2022 Nov; 187(5):730-742. PubMed ID: 35762296
[TBL] [Abstract][Full Text] [Related]
35. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
36. Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Iyengar S; Williamson PR; Schmitt J; Johannsen L; Maher IA; Sobanko JF; Cartee TV; Schlessinger D; Poon E; Alam M
Trials; 2016 Sep; 17(1):429. PubMed ID: 27580586
[TBL] [Abstract][Full Text] [Related]
37. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals.
van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO;
Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177
[TBL] [Abstract][Full Text] [Related]
38. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research.
Oei W; Fledderus AC; Spuls PI; Eggen CAM; Kottner J; van der Horst CMAM; Wolkerstorfer A; van Kessel MS; Krengel S; Etchevers HC; Korfage IJ; Pasmans SGM
Br J Dermatol; 2021 Aug; 185(2):371-379. PubMed ID: 33237568
[TBL] [Abstract][Full Text] [Related]
39. Quality of Life in Hand Eczema Questionnaire: Validation of the Japanese version of a disease-specific measure of quality of life for hand eczema patients.
Minamoto K; Diepgen TL; Sato K; Noguchi H; Yamashita N; Yoshimura K; Ofenloch RF
J Dermatol; 2018 Nov; 45(11):1301-1305. PubMed ID: 30264908
[TBL] [Abstract][Full Text] [Related]
40. A core outcome set for randomised controlled trials of physical activity interventions: development and challenges.
Crocker H; Peters M; Foster C; Black N; Fitzpatrick R
BMC Public Health; 2022 Feb; 22(1):389. PubMed ID: 35209864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
